The Effect of Cyclophosphamide on 2-Aminoanthracene Carcinogenesis in Rat Skin  by Dobson, Richard L.
THE EFFECT OF CYCLOPHOSPHAMIDE ON 2-AMINOANTHRACENE
CARCINOGENESIS IN RAT SKIN*
RICHARD L. DOBSON, M.D.
The repeated application of 2-aminoanthracene
(2-AA) to the skin of rats produces tumors de-
rived from both epithelial structures and connec-
tive tissue (1). Although basal cell epitheliomas
are most frequent, squamous cell carcinomas and
fibrosarcomas also occur. Usually two or more
varieties of tumor are present in the same animal.
These circumstances, therefore, provide an oppor-
tunity to observe the effects of an antitumor agent
on a number of distinct tumors simultaneously in
the same animal. Cyclophosphamide (CP) has
been widely used in the treatment of neoplastic
diseases. It has an effect on epithelial carcinomas
as well as tumors of mesodermal origin (2). Be-
cause of its broad-spectrum of action, cyclophos-
phamide was selected for this study.
MATERIAL AND METHODS
116 male albino rats (Carworth Farms) were
painted twice weekly on the skin of tbe back
with 1% 2-aminoanthracene in acetone. The
animals were divided into 4 groups, 3 of which
were treated additionally witb cyclophosphamide.
Group I received 0.1 mg of CP in 0.85% saline
intraperitoneally twice weekly; Group II, 0.25
mg and Group III, 0.5 mg. There were 12 animals
in each of these groups. Group IV consisted of 80
animals which were painted with the carcinogen
only. After 34 to 36 weeks all surviving animals
were killed and an area of painted skin removed.
The tissue was placed in Helley's fixative, em-
bedded in paraffin and serially sectioned. Sections
were stained with the following: hematoxylin
and eosin, Luxol fast blue (3), periodic acid-
Schiff, Mowry's colloidal iron (4), Giemsa, hema-
toxylin and azophloxine or the Pentachrome I
method of Movat (5).
RESULTS
During the study 2 rats in Group I died, 1 in
Group II and 4 in Group IV. All animals in Group
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III were dead within a few weeks presumably
because of the excessive amount of CP adminis-
tered.
The overall results in the surviving animals are
shown in Fig. 1. Four types of tumors accounted
for virtually all the malignancies—squamous cell
carcinoma, basal cell carcinoma, sebaceous gland
carcinoma and fibrosarcoma. The rate of occur-
rence of all these tumors with the exception of
the basal cell epithelioma was affected by treat-
ment with CF.
Squamous cell carcinomas were seen in 36% of
the control animals (Group IV). With CF the
rate was approximately doubled in Groups I and
II. For the most part the squamous cell carcin-
omas in Group I were small and most were well-
differentiated. Such tumors were the exception
in the CF treated groups in which highly ana-
plastic, invasive squamous cell carcinomas were
frequently noted.
The incidence of basal cell epitheliomas was
about the same in all 3 groups (Group I 92%,
group 11—80%, Group IV—90%). In addition, no
no qualitative differences between the tumors in
each group could be determined.
Tumors with sebaceous gland differentiation
were increased approximately threefold in the CF-
treated animals. Except for the difference in in-
cidence these tumors were similar in appearance
in all groups.
A decrease in the number of fibrosarcomas with
CF was noted which appeared to be dose related.
60% of Group IV had fibrosarcomas. In rats
given 0.1 mg CF the incidence was 40% and in
those given 0.25 mg the rate was further de-
creased to 18%. In all groups, however, the
fibrosarcomas were of similar appearance.
The response of the dermis to the application of
2-AA was similar in all groups and in no way
differed from that which we have previously
described (1). The upper dermis contained large
amounts of Mowry colloidal iron-positive mate-
rial. Collagen fibers in the mid and upper dermis
failed to stain with Luxol fast blue. Throughout
the dermis large numbers of mast cells were
present.
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• Aminoonthrocene alone
Aminnonth,ocene + 0.1 mg Cyclophoophofllde
C Aminoonthrocene + 0.25mg Cyclophoophomide
DISCUSSION
In 1948, Gomori (6) demonstrated increased
amounts of phosphamidase in malignant tissue.
Cyclophosphamide, a phosphamide ester of
nitrogen mustard, is, therefore, converted to an
active, cytotoxic form within malignant cells.
This dmg has been used with varying success in
the therapy of various malignancies of both epi-
thelial and mesodermal origin (2). Since all the
tumors produced in this study with 2-AA con-
tained phosphamidase activity a decreased inci-
dence of tumors would be expected. Only with
fibrosarcomas, however, was this the case. The
incidence of basal dcli epitheliomas was, in fact,
unaltered and that of squamous cell carcinomas
actually increased.
In an earlier study the effect of 2-AA on rat
skin was shown to involve the dermis initially
(1). It was only after disruption of the basement
membrane had occurred that invasive basal ccli
epitheliomas developed particularly when the
surrounding stroma was rich in acid mucopoly-
saccharide. This study suggested that tumors
derived from basal cells were not tmly malignant
but represented an expression of the inherent
hyperplastic potentialities of these cells when the
restraining influence of an intact dermis had been
removed. This concept is supported by the pres-
ent study since cyclophosphamide did not affect
the connective tissue response to 2-AA and the
incidence of basal cell epitheliomas was not
altered.
Although CP apparently increased the inci-
dence of tumors of sebaceous gland origin, the
actual numbers of such tumors was small in each
group. For this reason, the results in this case
are uncertain and, in any event, uninterpretable.
Squamous cell carcinomas appeared to be
potentiated by cyclophosphamide. That anti-
tumor agents can act as co-carcinogens has been
observed previously. If mice being painted with
methylcholanthrene, for example, are also given
metbotrexate, the incidence of epitheliomas is
increased (7). The mechanism of this phenomenon
is not known although a study of Des Prez and
Kiehn (8) is quite provocative. They observed
the healing of granulating wounds in untreated
mice and in those also given CP in varying doses.
Tbe proliferating epithelium of mice given large
amounts of CP appeared relatively immature
with large hyperchromatic nuclei and abundant
cytoplasm. Pseudo-epitheliomatous hyperpiasia
resulted. Control animals did not show this
response. Since CP also affected the dermal
component of the wound this study is difficult
to interpret. Regardless of mechanism, however,
the growth of epidermal squamous epithelium
does appear to be enhanced by CP.
The number of flbrosarcomas was reduced in
the CP-treated animals. Although experience is
limited in human fibrosarcomas, in general,
tumors of mesodermal origin tend to respond
more favorably to CP than do epithelial tumors.
Thus the decreased number of fibrosarcomas in
in the CP-trcated rats would be reasonably ex-
pected. What is not known, however, is whether
CP prevented the development of sarcomas or
destroyed them after their development. Since
serial biopsy specimens were not obtained, this
important question is unanswerable.
SUMMAEY
The incidence of tumors in rats painted with
2-amiuoanthracene and in rats painted with
2-aminoanthracene and treated with cyclophos-
phamide has been compared. Basal cell carcino-
mas occurred with equal frequency in all groups
supporting the concept that stromai factors play
the predominant role in the genesis of these
tumors. The incidence of squamous cell carcino-
mas was markedly increased by cyclophos-
phamide. Cyclophosphamide decreased the num-
ber of fibrosarcomas and this appeared to be dose
related. It could not be determined whether
cyclophosphamide prevented the development
of these tumors or destroyed them after their
development.
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DISCUSSION
DR. JOHN H. EPSvETN (San Francisco, Cali-
fornia): Just a comment about the effects of
antimetabolites on tumor formation. In experi-
mental chemical tumor formation the production
of tumors is significantly influenced by the status
of the hnir cycle. Chemical carcinogens are much
more effective when they are applied during the
resting phase Since the antimetabolites tend to
inhibit the growth phase of the cycle this may
have had an important effect on Dr. Dobson's
study.
DR. EUGENE J. VAN Scon (Bethesda, Md.):
Work such as this, of course, has many implica-
tions. Questions are brought up by Dr. Dobson's
findings, which, I am sure, he will pursue. The
alkylating agents, as a class, arc known to be
carcinogenic. Has cytoxan alone been given to a
comparable group of animals?
DR. RICHARD L. DoBsoN (in closing): The
growth cycle of the hair may certainly be ex-
tremely important, and I would not doubt that
Cytoxan has some effect on hair cycles. I cannot
answer any questions with regard to what in-
fluence it may have had in this study, because we
did not look into this.
We did not give Cytoxan alone. It may well
be carcinogenic in mice or in the rats that we
used, but we have no evidence to this effect.
